Artificial Intelligence in Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB511245180

Publication Date:

November 4, 2024

Pages:

106

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

IT Services [2]

Computing & Electronics [3]

Description:

The implementation of artificial intelligence (AI) technology in medical diagnostic devices and systems has changed the way patients are treated and diagnosed in the healthcare industry.Artificial intelligence is mainly used in medical institutions to check the correlation between treatment procedures and patient prognosis.After successful deployment and success, AI technology is likely to be widely used in medical practice, including medical imaging, drug development, personalized medicine and patient monitoring and care.The use of AI technology and machine learning in diagnostics can strengthen the growth of the global market by improving patient safety to improve diagnostic accuracy and reduce costs.
The global market for Artificial Intelligence in Diagnostics was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Artificial Intelligence in Diagnostics, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Artificial Intelligence in Diagnostics by region & country, by Type, and by Application.
The Artificial Intelligence in Diagnostics market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Intelligence in Diagnostics.
Market Segmentation
By Company
Aidoc Medical
AliveCor
GE Healthcare
Siemens Healthineers AG
Imagen Technologies锛孖nc
Vuno Inc
IDx Technologies Inc
NovaSignal Corporation
Riverain Technologies
Zebra Medical Vision
OSPLabs
Philips
Segment by Type:
Software
Hardware
Services
Segment by Application
Cardiology
Oncology
Pathology
Radiology
Chest and Lung
Neurology
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Artificial Intelligence in Diagnostics manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Artificial Intelligence in Diagnostics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Artificial Intelligence in Diagnostics in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Market Overview
1.1 Artificial Intelligence in Diagnostics Product Introduction
1.2 Global Artificial Intelligence in Diagnostics Market Size Forecast
1.3 Artificial Intelligence in Diagnostics Market Trends & Drivers
1.3.1 Artificial Intelligence in Diagnostics Industry Trends
1.3.2 Artificial Intelligence in Diagnostics Market Drivers & Opportunity
1.3.3 Artificial Intelligence in Diagnostics Market Challenges
1.3.4 Artificial Intelligence in Diagnostics Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Artificial Intelligence in Diagnostics Players Revenue Ranking (2023)
2.2 Global Artificial Intelligence in Diagnostics Revenue by Company (2019-2024)
2.3 Key Companies Artificial Intelligence in Diagnostics Manufacturing Base Distribution and Headquarters
2.4 Key Companies Artificial Intelligence in Diagnostics Product Offered
2.5 Key Companies Time to Begin Mass Production of Artificial Intelligence in Diagnostics
2.6 Artificial Intelligence in Diagnostics Market Competitive Analysis
2.6.1 Artificial Intelligence in Diagnostics Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Artificial Intelligence in Diagnostics Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Intelligence in Diagnostics as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Software
3.1.2 Hardware
3.1.3 Services
3.2 Global Artificial Intelligence in Diagnostics Sales Value by Type
3.2.1 Global Artificial Intelligence in Diagnostics Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Artificial Intelligence in Diagnostics Sales Value, by Type (2019-2030)
3.2.3 Global Artificial Intelligence in Diagnostics Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Cardiology
4.1.2 Oncology
4.1.3 Pathology
4.1.4 Radiology
4.1.5 Chest and Lung
4.1.6 Neurology
4.1.7 Others
4.2 Global Artificial Intelligence in Diagnostics Sales Value by Application
4.2.1 Global Artificial Intelligence in Diagnostics Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Artificial Intelligence in Diagnostics Sales Value, by Application (2019-2030)
4.2.3 Global Artificial Intelligence in Diagnostics Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Artificial Intelligence in Diagnostics Sales Value by Region
5.1.1 Global Artificial Intelligence in Diagnostics Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Artificial Intelligence in Diagnostics Sales Value by Region (2019-2024)
5.1.3 Global Artificial Intelligence in Diagnostics Sales Value by Region (2025-2030)
5.1.4 Global Artificial Intelligence in Diagnostics Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Artificial Intelligence in Diagnostics Sales Value, 2019-2030
5.2.2 North America Artificial Intelligence in Diagnostics Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Artificial Intelligence in Diagnostics Sales Value, 2019-2030
5.3.2 Europe Artificial Intelligence in Diagnostics Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Artificial Intelligence in Diagnostics Sales Value, 2019-2030
5.4.2 Asia Pacific Artificial Intelligence in Diagnostics Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Artificial Intelligence in Diagnostics Sales Value, 2019-2030
5.5.2 South America Artificial Intelligence in Diagnostics Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Artificial Intelligence in Diagnostics Sales Value, 2019-2030
5.6.2 Middle East & Africa Artificial Intelligence in Diagnostics Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Artificial Intelligence in Diagnostics Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Artificial Intelligence in Diagnostics Sales Value
6.3 United States
6.3.1 United States Artificial Intelligence in Diagnostics Sales Value, 2019-2030
6.3.2 United States Artificial Intelligence in Diagnostics Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Artificial Intelligence in Diagnostics Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Artificial Intelligence in Diagnostics Sales Value, 2019-2030
6.4.2 Europe Artificial Intelligence in Diagnostics Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Artificial Intelligence in Diagnostics Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Artificial Intelligence in Diagnostics Sales Value, 2019-2030
6.5.2 China Artificial Intelligence in Diagnostics Sales Value by Type (%), 2023 VS 2030
6.5.3 China Artificial Intelligence in Diagnostics Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Artificial Intelligence in Diagnostics Sales Value, 2019-2030
6.6.2 Japan Artificial Intelligence in Diagnostics Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Artificial Intelligence in Diagnostics Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Artificial Intelligence in Diagnostics Sales Value, 2019-2030
6.7.2 South Korea Artificial Intelligence in Diagnostics Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Artificial Intelligence in Diagnostics Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Artificial Intelligence in Diagnostics Sales Value, 2019-2030
6.8.2 Southeast Asia Artificial Intelligence in Diagnostics Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Artificial Intelligence in Diagnostics Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Artificial Intelligence in Diagnostics Sales Value, 2019-2030
6.9.2 India Artificial Intelligence in Diagnostics Sales Value by Type (%), 2023 VS 2030
6.9.3 India Artificial Intelligence in Diagnostics Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Aidoc Medical
7.1.1 Aidoc Medical Profile
7.1.2 Aidoc Medical Main Business
7.1.3 Aidoc Medical Artificial Intelligence in Diagnostics Products, Services and Solutions
7.1.4 Aidoc Medical Artificial Intelligence in Diagnostics Revenue (US$ Million) & (2019-2024)
7.1.5 Aidoc Medical Recent Developments
7.2 AliveCor
7.2.1 AliveCor Profile
7.2.2 AliveCor Main Business
7.2.3 AliveCor Artificial Intelligence in Diagnostics Products, Services and Solutions
7.2.4 AliveCor Artificial Intelligence in Diagnostics Revenue (US$ Million) & (2019-2024)
7.2.5 AliveCor Recent Developments
7.3 GE Healthcare
7.3.1 GE Healthcare Profile
7.3.2 GE Healthcare Main Business
7.3.3 GE Healthcare Artificial Intelligence in Diagnostics Products, Services and Solutions
7.3.4 GE Healthcare Artificial Intelligence in Diagnostics Revenue (US$ Million) & (2019-2024)
7.3.5 Siemens Healthineers AG Recent Developments
7.4 Siemens Healthineers AG
7.4.1 Siemens Healthineers AG Profile
7.4.2 Siemens Healthineers AG Main Business
7.4.3 Siemens Healthineers AG Artificial Intelligence in Diagnostics Products, Services and Solutions
7.4.4 Siemens Healthineers AG Artificial Intelligence in Diagnostics Revenue (US$ Million) & (2019-2024)
7.4.5 Siemens Healthineers AG Recent Developments
7.5 Imagen Technologies锛孖nc
7.5.1 Imagen Technologies锛孖nc Profile
7.5.2 Imagen Technologies锛孖nc Main Business
7.5.3 Imagen Technologies锛孖nc Artificial Intelligence in Diagnostics Products, Services and Solutions
7.5.4 Imagen Technologies锛孖nc Artificial Intelligence in Diagnostics Revenue (US$ Million) & (2019-2024)
7.5.5 Imagen Technologies锛孖nc Recent Developments
7.6 Vuno Inc
7.6.1 Vuno Inc Profile
7.6.2 Vuno Inc Main Business
7.6.3 Vuno Inc Artificial Intelligence in Diagnostics Products, Services and Solutions
7.6.4 Vuno Inc Artificial Intelligence in Diagnostics Revenue (US$ Million) & (2019-2024)
7.6.5 Vuno Inc Recent Developments
7.7 IDx Technologies Inc
7.7.1 IDx Technologies Inc Profile
7.7.2 IDx Technologies Inc Main Business
7.7.3 IDx Technologies Inc Artificial Intelligence in Diagnostics Products, Services and Solutions
7.7.4 IDx Technologies Inc Artificial Intelligence in Diagnostics Revenue (US$ Million) & (2019-2024)
7.7.5 IDx Technologies Inc Recent Developments
7.8 NovaSignal Corporation
7.8.1 NovaSignal Corporation Profile
7.8.2 NovaSignal Corporation Main Business
7.8.3 NovaSignal Corporation Artificial Intelligence in Diagnostics Products, Services and Solutions
7.8.4 NovaSignal Corporation Artificial Intelligence in Diagnostics Revenue (US$ Million) & (2019-2024)
7.8.5 NovaSignal Corporation Recent Developments
7.9 Riverain Technologies
7.9.1 Riverain Technologies Profile
7.9.2 Riverain Technologies Main Business
7.9.3 Riverain Technologies Artificial Intelligence in Diagnostics Products, Services and Solutions
7.9.4 Riverain Technologies Artificial Intelligence in Diagnostics Revenue (US$ Million) & (2019-2024)
7.9.5 Riverain Technologies Recent Developments
7.10 Zebra Medical Vision
7.10.1 Zebra Medical Vision Profile
7.10.2 Zebra Medical Vision Main Business
7.10.3 Zebra Medical Vision Artificial Intelligence in Diagnostics Products, Services and Solutions
7.10.4 Zebra Medical Vision Artificial Intelligence in Diagnostics Revenue (US$ Million) & (2019-2024)
7.10.5 Zebra Medical Vision Recent Developments
7.11 OSPLabs
7.11.1 OSPLabs Profile
7.11.2 OSPLabs Main Business
7.11.3 OSPLabs Artificial Intelligence in Diagnostics Products, Services and Solutions
7.11.4 OSPLabs Artificial Intelligence in Diagnostics Revenue (US$ Million) & (2019-2024)
7.11.5 OSPLabs Recent Developments
7.12 Philips
7.12.1 Philips Profile
7.12.2 Philips Main Business
7.12.3 Philips Artificial Intelligence in Diagnostics Products, Services and Solutions
7.12.4 Philips Artificial Intelligence in Diagnostics Revenue (US$ Million) & (2019-2024)
7.12.5 Philips Recent Developments
8 Industry Chain Analysis
8.1 Artificial Intelligence in Diagnostics Industrial Chain
8.2 Artificial Intelligence in Diagnostics Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Artificial Intelligence in Diagnostics Sales Model
8.5.2 Sales Channel
8.5.3 Artificial Intelligence in Diagnostics Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Aidoc Medical
AliveCor
GE Healthcare
Siemens Healthineers AG
Imagen Technologies锛孖nc
Vuno Inc
IDx Technologies Inc
NovaSignal Corporation
Riverain Technologies
Zebra Medical Vision
OSPLabs
Philips

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂